| Zoetis is a holding company. Through its subsidiaries, Co. is engaged in the discovery, development, manufacture and commercialization of animal health medicines, vaccines, and diagnostic products with a focus on both livestock and companion animals. Co. operates in two segments: the United States and International. Co.'s main product categories are vaccines, anti-infectives, parasiticides, other pharmaceutical products, dermatology products, medicated feed additives, and animal health diagnostics. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services including biodevices, genetic tests and precision livestock farming. We show 30 historical shares outstanding datapoints in our coverage of ZTS's shares outstanding history.|
Understanding the changing numbers of Zoetis shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like Zoetis versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching Zoetis by allowing them to research Zoetis shares outstanding history
as well as any other stock in our coverage universe.